2143 Regorafenib for previously treated metastatic colorectal cancer (mCRC): Results from 683 Italian patients treated in the open-label phase 3B CONSIGN study
Ciardiello, F., Falcone, A., Cascinu, S., Sobrero, A., Boni, C., Barone, C., Luppi, G., Maiello, E., Siena, S., Zagonel, V., Carteni, G., Constanzo, F. Di, Bartolomeo, M. Di, Santoro, A., Russo, A., MVolume:
51
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(16)31064-4
Date:
September, 2015
File:
PDF, 72 KB
english, 2015